Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain episode artwork

EPISODE · May 12, 2025 · 26 MIN

Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain

from Markets Plus · host BMO

During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.

During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.

NOW PLAYING

Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain

0:00 26:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Markets Plus?

This episode is 26 minutes long.

When was this Markets Plus episode published?

This episode was published on May 12, 2025.

What is this episode about?

During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with...

Can I download this Markets Plus episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!